Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanta Subbarao

Showing results (201-210 of 300) with videos related to

Pageof 30
Sort By:
Vaccine|May 26, 2009
A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adultsKawsar R Talaat, Ruth A Karron, Karen A Callahan, et al.
Nature Communications|March 4, 2021
Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaquesHyon-Xhi Tan, Jennifer A Juno, Wen Shi Lee, et al.
Influenza and Other Respiratory Viruses|November 4, 2024
Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UKJoanna Waldock, Rebecca J Cox, Christopher Chiu, et al.
Vaccine|October 20, 2006
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitroYiu Wing Kam, François Kien, Anjeanette Roberts, et al.
The Journal of Infectious Diseases|August 8, 2020
Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence SettingKatherine Bond, Suellen Nicholson, Seok Ming Lim, et al.
Ebiomedicine|April 25, 2024
Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trialNicole L Messina, Susie Germano, Rebecca McElroy, et al.
Emerging Infectious Diseases|May 21, 2021
Persistence of SARS-CoV-2-Specific IgG in Children 6 Months After Infection, AustraliaZheng Quan Toh, Rachel A Higgins, Lien Anh Ha Do, et al.
Frontiers in Pharmacology|April 1, 2022
ACE2 Expression in Organotypic Human Airway Epithelial Cultures and Airway BiopsiesQianyu Chen, Shenna Langenbach, Meina Li, et al.
Frontiers in Immunology|April 25, 2022
Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 <i>In Vitro</i> InfectionJessie J-Y Chang, Josie Gleeson, Daniel Rawlinson, et al.
Viruses|March 26, 2022
Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) VirusesAnnette Fox, Louise Carolan, Vivian Leung, et al.
Pageof 30

Showing results (201-210 of 300) with videos related to

Sort By:
Pageof 30
Vaccine|May 26, 2009
A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adultsKawsar R Talaat, Ruth A Karron, Karen A Callahan, et al.
Nature Communications|March 4, 2021
Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaquesHyon-Xhi Tan, Jennifer A Juno, Wen Shi Lee, et al.
Influenza and Other Respiratory Viruses|November 4, 2024
Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UKJoanna Waldock, Rebecca J Cox, Christopher Chiu, et al.
Vaccine|October 20, 2006
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitroYiu Wing Kam, François Kien, Anjeanette Roberts, et al.
The Journal of Infectious Diseases|August 8, 2020
Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence SettingKatherine Bond, Suellen Nicholson, Seok Ming Lim, et al.
Ebiomedicine|April 25, 2024
Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trialNicole L Messina, Susie Germano, Rebecca McElroy, et al.
Emerging Infectious Diseases|May 21, 2021
Persistence of SARS-CoV-2-Specific IgG in Children 6 Months After Infection, AustraliaZheng Quan Toh, Rachel A Higgins, Lien Anh Ha Do, et al.
Frontiers in Pharmacology|April 1, 2022
ACE2 Expression in Organotypic Human Airway Epithelial Cultures and Airway BiopsiesQianyu Chen, Shenna Langenbach, Meina Li, et al.
Frontiers in Immunology|April 25, 2022
Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 <i>In Vitro</i> InfectionJessie J-Y Chang, Josie Gleeson, Daniel Rawlinson, et al.
Viruses|March 26, 2022
Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) VirusesAnnette Fox, Louise Carolan, Vivian Leung, et al.
Pageof 30